CRISPR Nobelists surrender their own European patents
Technology tamfitronics A strategic move by lawyers acting for Doudna and Charpentier is the latest twist in the battleground for CRISPRCas9 technology. Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 24,99 /30days cancel any time Subscribe to this journal Receive 12 print issues and online access 214,86 […]
